GlassScriptPhysician profile
Francisco Vega
NPI 1538422704
$9,454.60
in general payments reported to CMS, 2019-2025
29 companies · $870 in 2025
The $870 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,579 · 2020: $178 · 2021: $1,007 · 2022: $691 · 2023: $2,008 · 2024: $1,122 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,996 · Travel and Lodging: $3.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,996.39 |
| Travel and Lodging | $3.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $3,336.63 | 2019-2020 | |
| Cardiovascular Systems INC. | $1,238.99 | 2020-2023 | Diamondback Peripheral, Diamondback Coronary |
| Abbott Laboratories | $844.66 | 2021-2025 | Diamondback Peripheral, Supera, Esprit |
| Koya Medical, INC. | $569.22 | 2023-2025 | Dayspring, Dayspring, Koya Medical |
| Shockwave Medical, INC | $469.37 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $421.10 | 2021-2025 | Varithena Administration Pack, Ranger, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $330.58 | 2021-2025 | Venclose Maven Catheter, Covera, Fluency Endovascular Stent Graft |
| Philips North America LLC | $290.63 | 2024-2025 | Laser Service and Other, (P84) Igt Devices Systems, (Bs2) Lm Undivided |
| Integra Lifesciences Corporation | $286.42 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Silk Road Medical, INC. | $262.96 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Smith+Nephew, INC. | $199.19 | 2021-2023 | Collagenase Santyl |
| Ekos Corporation | $180.15 | 2019 | |
| Becton, Dickinson and Company | $147.44 | 2023-2024 | Venclose Maven Catheter, Venovo |
| W. L. Gore & Associates, INC. | $137.92 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis |
| Medtronic, INC. | $135.36 | 2021-2023 | Intellis Adaptivestim |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $125.00 | 2022 | |
| Angiodynamics, INC. | $76.47 | 2024 | Auryon Laser System 100-120 Vac |
| Mallinckrodt Enterprises LLC | $59.91 | 2019 | |
| Novo Nordisk INC | $49.07 | 2023 | Wegovy, Rybelsus, Ozempic |
| Tactile Systems Technology INC | $48.59 | 2025 | Nimbl, Flexitouch Plus |
| Cook Medical LLC | $46.44 | 2023 | Flexor, Zilver Vena |
| Pfizer INC. | $37.84 | 2019 | |
| Inspiremd LTD | $35.36 | 2025 | Cguard Prime Carotid Stent System |
| Tela Bio, INC. | $26.85 | 2024 | Ovitex 2s |
| Getinge USA Sales, LLC | $24.41 | 2019-2020 | |
| Penumbra, INC. | $23.22 | 2023 | Indigo System |
| Bolton Medical INC | $18.72 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Aroa Biosurgery Incorporated | $16.45 | 2023 | |
| Imperative Care, INC | $15.65 | 2025 | Symphony Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.